BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson TL, Toliver JC, Mao L, Oramasionwu CU. Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study. BMC Infect Dis. 2014;14:217. [PMID: 24755037 DOI: 10.1186/1471-2334-14-217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Boucher LM, Bayoumi AM, Mark AE, Cooper C, Martin A, Marshall Z, Boyd R, Oickle P, Diliso N, Pineau D, Renaud B, LeBlanc S, Tyndall M, Lee OM, Kendall CE. Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort Study. Subst Use Misuse 2019;54:18-30. [PMID: 29932800 DOI: 10.1080/10826084.2018.1485699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Roberson JL, Lagasca AM, Kan VL. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015. AIDS Res Hum Retroviruses 2018;34:148-55. [PMID: 28974107 DOI: 10.1089/AID.2017.0092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Oramasionwu CU, Kashuba ADM, Napravnik S, Wohl DA, Mao L, Adimora AA. Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection. World J Hepatol 2016; 8(7): 368-375 [PMID: 26981174 DOI: 10.4254/wjh.v8.i7.368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Katrak S, Park LP, Woods C, Muir A, Hicks C, Naggie S. Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease. Open Forum Infect Dis 2016;3:ofw173. [PMID: 27704025 DOI: 10.1093/ofid/ofw173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Athanasakis K, Naoum V, Naoum P, Nomikos N, Theodoratou D, Kyriopoulos J. A 10-year economic analysis of HIV management in Greece: evidence of efficient resource allocation. Curr Med Res Opin 2021;:1-7. [PMID: 34873979 DOI: 10.1080/03007995.2021.2015158] [Reference Citation Analysis]
6 Cotte L, Pugliese P, Valantin MA, Cuzin L, Billaud E, Duvivier C, Naqvi A, Cheret A, Rey D, Pradat P. Hepatitis C treatment initiation in HIV-HCV coinfected patients. BMC Infect Dis. 2016;16:345. [PMID: 27450098 DOI: 10.1186/s12879-016-1681-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
7 Frimpong JA, D'Aunno T, Perlman DC, Strauss SM, Mallow A, Hernandez D, Schackman BR, Feaster DJ, Metsch LR. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial. Trials 2016;17:117. [PMID: 26936623 DOI: 10.1186/s13063-016-1225-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Padam P, Clark S, Irving W, Gellissen R, Thomson E, Main J, Cooke GS. Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease. J Viral Hepat 2016;23:123-9. [PMID: 26511293 DOI: 10.1111/jvh.12484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Höner Zu Siederdissen C, Mederacke I. Editorial: diabetes in HIV-infected patients-do not blame the usual suspect! Aliment Pharmacol Ther 2018;48:481-2. [PMID: 30588691 DOI: 10.1111/apt.14863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]